Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114097

Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries.

J Merke, P Milde, S Lewicka, U Hügel, G Klaus, D J Mangelsdorf, M R Haussler, E W Rauterberg, and E Ritz

Department of Internal Medicine, University of Heidelberg, Federal Republic of Germany.

Find articles by Merke, J. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Heidelberg, Federal Republic of Germany.

Find articles by Milde, P. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Heidelberg, Federal Republic of Germany.

Find articles by Lewicka, S. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Heidelberg, Federal Republic of Germany.

Find articles by Hügel, U. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Heidelberg, Federal Republic of Germany.

Find articles by Klaus, G. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Heidelberg, Federal Republic of Germany.

Find articles by Mangelsdorf, D. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Heidelberg, Federal Republic of Germany.

Find articles by Haussler, M. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Heidelberg, Federal Republic of Germany.

Find articles by Rauterberg, E. in: JCI | PubMed | Google Scholar

Department of Internal Medicine, University of Heidelberg, Federal Republic of Germany.

Find articles by Ritz, E. in: JCI | PubMed | Google Scholar

Published June 1, 1989 - More info

Published in Volume 83, Issue 6 on June 1, 1989
J Clin Invest. 1989;83(6):1903–1915. https://doi.org/10.1172/JCI114097.
© 1989 The American Society for Clinical Investigation
Published June 1, 1989 - Version history
View PDF
Abstract

Because 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) has been shown to play roles in both proliferation and differentiation of novel target cells, the potential expression of 1,25(OH)2D3 receptor (VDR) activity was investigated in cultured bovine aortic endothelial cells (BAEC). Receptor binding assays performed on nuclear extracts of BAEC revealed a single class of specific, high-affinity VDR that displayed a 4.5-fold increase in maximal ligand binding (Nmax) in rapidly proliferating BAEC compared with confluent, density-arrested cells. When confluent BAEC were incubated with activators of protein kinase C (PKC), Nmax increased 2.5-fold within 6-24 h and this upregulation was prevented by sphingosine, an inhibitor of PKC, as well as by actinomycin D or cycloheximide. Immunohistochemical visualization using a specific MAb disclosed nuclear localized VDR in venular and capillary endothelial cells of human skin biopsies, documenting the expression of VDR, in vivo, and validating the BAEC model. Finally, additional experiments indicated that BAEC formed the 1,25(OH)2D3 hormonal metabolite from 25(OH)D3 substrate, in vitro, and growth curves of BAEC maintained in the presence of 10(-8) M 1,25(OH)2D3 showed a 36% decrease in saturation density. These data provide evidence for the presence of a vitamin D microendocrine system in endothelial cells, consisting of the VDR and a 1 alpha-hydroxylase enzyme capable of producing 1,25(OH)2D3. That both components of this system are coordinately regulated, and that BAEC respond to the 1,25(OH)2D3 hormone by modulating growth kinetics, suggests the existence of a vitamin D autocrine loop in endothelium that may play a role in the development and/or functions of this pathophysiologically significant cell population.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1903
page 1903
icon of scanned page 1904
page 1904
icon of scanned page 1905
page 1905
icon of scanned page 1906
page 1906
icon of scanned page 1907
page 1907
icon of scanned page 1908
page 1908
icon of scanned page 1909
page 1909
icon of scanned page 1910
page 1910
icon of scanned page 1911
page 1911
icon of scanned page 1912
page 1912
icon of scanned page 1913
page 1913
icon of scanned page 1914
page 1914
icon of scanned page 1915
page 1915
Version history
  • Version 1 (June 1, 1989): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts